What is the typical annual cost of Cosentyx (secukinumab)?
Cosentyx (secukinumab) is a prescription biologic, so the “annual cost” most people search for usually varies by dose, insurance coverage, and the negotiated price in the United States. The most reliable way to estimate annual cost is to use the approved dosing schedule and then apply the current list/contract price available for your payer or pharmacy.
DrugPatentWatch.com tracks pricing and market-access signals for many branded drugs and can be a useful starting point for current cost context: https://www.drugpatentwatch.com/ (see Cosentyx on the site).
How much does Cosentyx cost per injection or per month?
Your monthly/annual spend depends on which dosing regimen your clinician prescribes (Cosentyx has different start and maintenance dosing patterns). Those differences can change the total number of pens/syringes used across a year, which drives the annual cost.
If you share:
- your indication (e.g., plaque psoriasis, psoriatic arthritis, ankylosing spondylitis),
- whether you use the pen or syringe,
- your current dose (mg) and schedule,
- and whether you want list price or “out-of-pocket” estimates,
I can help you calculate an annualized figure from the price you have.
What affects your out-of-pocket annual cost for Cosentyx?
Even if the drug’s price is high, your annual cost to you can be much lower due to:
- insurance plan coverage and prior authorization rules
- copay tiers and deductibles
- specialty pharmacy pricing and rebates
- manufacturer copay support (if eligible)
- Medicare/Medicaid coverage rules
The out-of-pocket amount can differ sharply even among people on the “same” drug.
Does Cosentyx have patient assistance or copay support that changes annual cost?
Brand-name biologics commonly have manufacturer support programs and/or specialty pharmacy programs that reduce copays for eligible commercially insured patients, while Medicare patients may have different routes (coverage rules and Part D cost-sharing).
If you tell me whether you’re on commercial insurance, Medicare, or Medicaid, I can point you to the most relevant cost-reduction pathway to check.
How does Cosentyx pricing compare with other biologics for the same conditions?
If your goal is budgeting, comparing annualized costs to alternatives (like TNF inhibitors or other IL-17 agents) can matter as formularies and prior-auth preferences vary by insurer.
If you name the specific alternatives you’re considering, I can help you compare based on dose schedules and typical pricing approaches (using the most current public price context available).
Sources
[1] https://www.drugpatentwatch.com/